- Home
- SLN vs TITN Comparison
SLN vs TITN Comparison
Compare SLN & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLN
- TITN
- Stock Information
- Founded
- SLN 1994
- TITN 1980
- Country
- SLN United Kingdom
- TITN United States
- Employees
- SLN N/A
- TITN N/A
- Industry
- SLN Biotechnology: Pharmaceutical Preparations
- TITN Other Specialty Stores
- Sector
- SLN Health Care
- TITN Consumer Discretionary
- Exchange
- SLN Nasdaq
- TITN Nasdaq
- Market Cap
- SLN 299.4M
- TITN 341.6M
- IPO Year
- SLN N/A
- TITN 2007
- Fundamental
- Price
- SLN $4.81
- TITN $20.00
- Analyst Decision
- SLN Buy
- TITN Buy
- Analyst Count
- SLN 5
- TITN 4
- Target Price
- SLN $32.60
- TITN $22.25
- AVG Volume (30 Days)
- SLN 60.5K
- TITN 150.1K
- Earning Date
- SLN 08-07-2025
- TITN 08-28-2025
- Dividend Yield
- SLN N/A
- TITN N/A
- EPS Growth
- SLN N/A
- TITN N/A
- EPS
- SLN N/A
- TITN N/A
- Revenue
- SLN $27,169,000.00
- TITN $2,580,509,000.00
- Revenue This Year
- SLN N/A
- TITN N/A
- Revenue Next Year
- SLN N/A
- TITN $0.57
- P/E Ratio
- SLN N/A
- TITN N/A
- Revenue Growth
- SLN 22.28
- TITN N/A
- 52 Week Low
- SLN $1.97
- TITN $12.50
- 52 Week High
- SLN $20.48
- TITN $23.41
- Technical
- Relative Strength Index (RSI)
- SLN 34.88
- TITN 51.37
- Support Level
- SLN $4.91
- TITN $18.86
- Resistance Level
- SLN $5.34
- TITN $21.57
- Average True Range (ATR)
- SLN 0.48
- TITN 0.77
- MACD
- SLN -0.05
- TITN 0.06
- Stochastic Oscillator
- SLN 0.71
- TITN 42.07
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
About TITN Titan Machinery Inc.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.